Výsledky vyhledávání - "over-treatment"

Report

Clinical dichotomania: A major cause of over-diagnosis and over-treatment?

Autor: Llewelyn, Huw

Introduction: There have been many warnings that inappropriate dichotomisation of results into positive or negative, high, or normal etc., during medical research could be very damaging. The aim of this paper is to argue that this is the main cause o

Externí odkaz: http://arxiv.org/abs/2309.07194

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Latent tuberculosis infection and biologic agents other than TNF-α inhibitors: 'over-screening and over-treatment?'

Autor: Ana Paula Santos, Fernanda Carvalho de Queiroz Mello

Publikováno v: Jornal Brasileiro de Pneumologia, Vol 50, Iss 4 (2024)

Externí odkaz: https://doaj.org/article/a967b245806e4e76ac6f823f11fb15c3

Zobrazit plný text záznamu

Akademický článek

Dangers of under-treatment and over-treatment with inhaled corticosteroids in children with asthma.

Autor: Hayes B; West Virginia University School of Medicine, Morgantown, West Virginia, USA., Mahady S; West Virginia University School of Medicine, Morgantown, West Virginia, USA., McGuire A; Central Arkansas Pediatric Clinic, Benton, Arkansas, USA., Sforza A; Juniata College, Huntingdon, Pennsylvania, USA., Sforza J; Juniata College, Huntingdon, Pennsylvania, USA., Piedimonte G; Tulane School of Medicine, New Orleans, Louisiana, USA., Skoner DP; West Virginia University School of Medicine, Morgantown, West Virginia, USA.

Publikováno v: Pediatric pulmonology [Pediatr Pulmonol] 2024 Nov 08. Date of Electronic Publication: 2024 Nov 08.

Zobrazit plný text záznamu

Akademický článek

Understanding Over-Treatment - Lessons from a Clinical Trial.

Autor: Ciavaglia B; Ms. Ciavaglia lives in Ottawa, ON.

Publikováno v: NEJM evidence [NEJM Evid] 2024 Oct; Vol. 3 (10), pp. EVIDpp2400269. Date of Electronic Publication: 2024 Sep 24.

Zobrazit plný text záznamu

Editorial & Opinion

Latent tuberculosis infection and biologic agents other than TNF-α inhibitors: "over-screening and over-treatment?"

Autor: Santos AP; Instituto de Doenças do Tórax - IDT - Universidade Federal do Rio de Janeiro - UFRJ - Rio de Janeiro (RJ) Brasil.; Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro - UERJ - Rio de Janeiro (RJ) Brasil., Mello FCQ; Instituto de Doenças do Tórax - IDT - Universidade Federal do Rio de Janeiro - UFRJ - Rio de Janeiro (RJ) Brasil.

Publikováno v: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia [J Bras Pneumol] 2024 Sep 27; Vol. 50 (4), pp. e20240277. Date of Electronic Publication: 2024 Sep 27.

Zobrazit plný text záznamu

Akademický článek

The clinical use of enfortumab vedotin and pembrolizumab in patients with advanced urothelial carcinoma: using clinical judgement over treatment criteria.

Autor: Apolo AB; Center for Cancer Research, National Cancer Institute, Bethesda., Bellmunt J; Dana Farber Cancer Institute, Boston., Cordes L; Center for Cancer Research, National Cancer Institute, Bethesda., Gupta S; Cleveland Clinic Taussig Cancer Institute, Cleveland, USA., Powles T; Barts Cancer Centre, London, UK. Electronic address: thomas.powles1@nhs.net., Rosenberg JE; Memorial Sloan Kettering, New York, USA., Van Der Heijden MS; National Cancer Institute (NKI), Amsterdam, the Netherlands.

Publikováno v: ESMO open [ESMO Open] 2024 Sep; Vol. 9 (9), pp. 103725. Date of Electronic Publication: 2024 Sep 05.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání